알테오젠
231,000KRWMarket close of 10/20 (Tue)
Down -3.35%-8,000KRWMarket close of 10/20 (Tue)
Preliminary value right after the close — replaced by official KRX data tomorrow morningClose of 10/21 (Wed)240,000KRWUp +3.90%
Preliminary · just after the close · replaced by official KRX data tomorrow morning
- Open
- 233,500
- High
- 238,000
- Low
- 226,000
- Day range
- Day range low 226,000 high 238,000, open 233,500, close 231,000, previous close 239,000
- Volume
- 22×10K shares
- 51.1B KRW 0.66× the 20-session average
Market close of 10/20 (Tue)
Where it sits in the 1-year range
5%1-year close range 213,500 to 559,000 won, 5% up from the low
5% of the way up from the lowest close in 1 year (252 sessions) · -58.7% from the high
Usual range
Nothing unusual in the 6 checked items
Free · no sign-inSource from 2021-05-17
Points to check
- Daily moveusual range-3.35%-3.35%, 1.5× the usual (20-session average ±2.23%)That day -3.35% · usual ±2.23% · large-move threshold ±4.5%
- Trading valueusual range0.7×51.1B KRW, 0.7× the 20-session average0.66× the 20-session average · check threshold 3×
- Earningsusual range119.8B KRWOperating income over the last four quarters 119.8B KRW
The other 3 are within the usual range
- Recent filings0Last 14 days
- Foreign & institutional+104.8B KRWusual range
- Data date10/20 (Tue)Market close
See the full check report
Same sector · 바이오 R&D
Down -2.19%· 16 of 64 stocks up, preferred shares excluded · trading value 190.5B KRW
| Stock | 20D | Change | Trading value |
|---|---|---|---|
| 올릭스 | Close over the last 20 sessions -12.2% | Down -4.03% | 19.1B KRW |
| 디앤디파마텍 | Close over the last 20 sessions -11.8% | Down -1.93% | 15.1B KRW |
| 리가켐바이오 | Close over the last 20 sessions -15.4% | Down -1.41% | 12.1B KRW |
| 프로티나 | Close over the last 20 sessions +31.8% | Up +7.38% | 10.0B KRW |
| 바이오인프라 | Close over the last 20 sessions +123.3% | Down -6.80% | 9.3B KRW |
Schedule
- Q3 report due · 11/16 (Mon) · in 25 days
- Next data 10/22 (Thu) after 08:50
For information only, not a solicitation to invest. Investment decisions and their results are your own responsibility.